Abstract
Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates
Author(s): Allen Loyd V Jr
Issue: May/Jun 2020 - Volume 24, Number 3
Page(s): 215-220
Abstract
Intravenous admixture compounding requires knowledge of stability, compatibility, and incompatibility issues related to the complete composition and formulation. In evaluating an intravenous admixture, one is not just concerned with the active ingredients but also with all the excipients. Both active pharmaceutical ingredients and excipients used in the formulations of commercially available products may vary among manufacturers and can influence drug compatibility and stability. Clinical pharmaceutics includes the study and application of pharmaceutics to clinical compounding situations to aid in the evaluation of each intravenous admixture. A critical aspect of successful intravenous admixture preparation is the prevention or minimization of particulate matter in the finished product. This article discusses the source, method of prevention, and detection of particulates in intravenous admixtures.
Related Keywords
- parenteral preparations
- drug admixtures
- intravenous administration
- compounded sterile preparations
- particulate sources
- adverse reactions
- visual inspection
- compounding standards
- United States Pharmacopeia
- USP
- filtration
Related Categories
- PARENTERALS
- STABILITIES, COMPATIBILITIES
- STERILE PREPARATIONS
- QUALITY CONTROL
Related Articles from IJPC
Issue/Page View/Buy |
Title/Author (Click for Abstract / Details / Purchase) |
---|---|
May/Jun 2020
Pg. 215-220
|
Author(s):
Allen Loyd V Jr
|
May/Jun 2022
Pg. 219-228
|
Author(s):
Allen Loyd V Jr
|
Mar/Apr 2021
Pg. 131-139
|
Author(s):
Allen Loyd V Jr
|
May/Jun 2021
Pg. 222-229
|
Author(s):
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 397-409
|
Author(s):
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 305-313
|
Author(s):
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 305-309
|
Author(s):
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 311-317
|
Author(s):
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 478-482
|
Author(s):
Allen Loyd V Jr
|
May/Jun 2023
Pg. 223-229
|
Author(s):
Allen Loyd V Jr
|
Jan/Feb 2021
Pg. 31-38
|
Author(s):
Allen Loyd V Jr
|
Jul/Aug 2022
Pg. 309-315
|
Author(s):
Summers Amy
|
Sep/Oct 2021
Pg. 403-408
|
Author(s):
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 44-50
|
Author(s):
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 123-139
|
Author(s):
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 491-496
|
Author(s):
Allen Loyd V Jr
|
Sep/Oct 2020
Pg. 397-402
|
Author(s):
Allen Loyd V Jr
|
Nov/Dec 2020
Pg. 473-478
|
Author(s):
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 395-404
|
Author(s):
Akers Michael J
|
Sep/Oct 2018
Pg. 387-398
|
Author(s):
Ashe Krystina, Baskett Dustin
|